Status:
UNKNOWN
Neurophysiological Mechanisms of Accelerated Resolution Therapy (ART)
Lead Sponsor:
University of South Florida
Conditions:
Depressive Symptoms
Stress Disorder, Acute
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In brief, ART is an innovative "mind-body" (body-centric) psychotherapy that makes use of established core components of trauma-focused therapy including imaginal exposure and imagery rescripting to p...
Detailed Description
Our long-term goal is to understand, from a mechanistic perspective, how ART appears to result in rapid, successful treatment of PTSD and related comorbidities. This knowledge will help to identify ta...
Eligibility Criteria
Inclusion
- Posttraumatic Stress Disorder (PTSD): Score of \> 33 on the 20-item DSM-V PTSD Checklist (PCL-V) or
- Depression: Score of \> 16 on the 20-item Center for Epidemiologic Depression Scale or
- Acute stress disorder: Presence of criterions A-E on the 19-item Acute Stress Disorder Scale or
- Complicated grief: Score of \> 25 on the 19-item Inventory of Complicated Grief or
- Alcohol abuse: Score of \> 10 on 10-item Alcohol Use Disorders Identification Test (AUDIT) and
- Corroboration of the above symptomatology through verification of the corresponding subscale of the 125-item Psychiatric Diagnostic Screening Questionnaire (PDSQ).
Exclusion
- Currently engaged in another psychotherapy regimen including currently engaged in ART or another eye movement therapy, such as EMDR;
- Have a major psychiatric disorder (e.g. bipolar disorder) deemed likely to interfere with treatment delivery;
- Currently in a formal substance dependence treatment program (alcohol and/or drug) anticipated to interfere with treatment delivery (e.g. through detox and symptoms of physiological withdrawal). All persons recruited for potential study participation will undergo a clinical intake assessment, with completion of ART intake form, by a licensed clinical therapist, to determine study eligibility.
Key Trial Info
Start Date :
November 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04121884
Start Date
November 1 2019
End Date
August 31 2020
Last Update
November 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of South Florida
Tampa, Florida, United States, 33612